Sequential hybrid ablation versus surgical CryoMaze alone for treatment of atrial fibrillation (SurHyb Trial): a protocol of the multicentre randomized controlled trial.

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00209775%3A_____%2F23%3AN0000004" target="_blank" >RIV/00209775:_____/23:N0000004 - isvavai.cz</a>

Alternative codes found

RIV/00216208:11120/23:43925478 RIV/00064173:_____/23:43925478 RIV/00098892:_____/23:10157905 RIV/00023001:_____/23:00083985 RIV/60076658:12110/23:43906772

Result on the web

<a href="https://jab.zsf.jcu.cz/pdfs/jab/2023/02/02.pdf" target="_blank" >https://jab.zsf.jcu.cz/pdfs/jab/2023/02/02.pdf</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.32725/jab.2023.007" target="_blank" >10.32725/jab.2023.007</a>

Result language

angličtina

Original language name

Sequential hybrid ablation versus surgical CryoMaze alone for treatment of atrial fibrillation (SurHyb Trial): a protocol of the multicentre randomized controlled trial.

Original language description

Atrial fibrillation is common in patients with structural heart disease who are undergoing cardiac surgery. Surgical CryoMaze has been shown to be an effective treatment in several trials, but success rates have varied considerably, between 47–95%. The sequential hybrid approach, combining surgical CryoMaze followed by radiofrequency catheter ablation, can achieve high freedom from atrial arrhythmias. However, in patients with concomitant surgical atrial fibrillation treatment, data comparing the hybrid approach to CryoMaze alone are lacking. Methods: The SurHyb study was designed as a prospective, open-label, multicentre randomized trial. Patients with non-paroxysmal atrial fibrillation who were scheduled for coronary artery bypass grafting or valve repair/replacement were randomized to either surgical CryoMaze alone or surgical CryoMaze followed by radiofrequency catheter ablation 3 months post-surgery. The primary outcome measure was arrhythmia-free survival without class I or III antiarrhythmic drugs, which has been evaluated using implantable cardiac monitors. Conclusions: This is the first randomized study that compares concomitant surgical CryoMaze alone with the staged hybrid surgical CryoMaze followed by catheter ablation, in patients with non-paroxysmal atrial fibrillation using rigorous rhythm monitoring. The results may contribute to the optimization of the treatment in patients undergoing concomitant CryoMaze for atrial fibrillation.

Czech name

—

Czech description

—

Type

J_imp - Article in a specialist periodical, which is included in the Web of Science database

CEP classification

—

OECD FORD branch

30201 - Cardiac and Cardiovascular systems

Project

<a href="/en/project/NV19-02-00046" target="_blank" >NV19-02-00046: Sequential Hybrid Ablation versus Surgical CryoMaze Alone for Treatment of Atrial Fibrillation (SurHyb Trial): a multicenter randomized controlled trial</a><br>

Continuities

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year

2023

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Journal of applied biomedicine

ISSN

1214-021X

e-ISSN

1214-0287

Volume of the periodical

—

Issue of the periodical within the volume

21

Country of publishing house

CZ - CZECH REPUBLIC

Number of pages

6

Pages from-to

67-72

UT code for WoS article

000991372700001

EID of the result in the Scopus database

2-s2.0-85163610637